Nanjing Vcare Was Successfully Selected as an "Innovative Small and Medium-sized Enterprise in Nanjing"

2023-04-17

Recently, the Nanjing Municipal Bureau of Industry and Information Technology publicized the "List of Proposed Recognition of Innovative Small and Medium-sized Enterprises in Nanjing in 2023". Nanjing Vcare was successfully selected, marking that the R&D and innovation capabilities of Nanjing Vcare have been further recognized.

 

 

"Innovative small and medium-sized enterprises" refer to high-quality small and medium-sized enterprises with a relatively high level of specialization, strong innovation capabilities and development potential. It is a "certification" symbol of an enterprise's innovation ability. The evaluation criteria include three categories and six indicators such as innovation ability, growth potential and specialization. Since its establishment, Nanjing Vcare has been deeply focusing on the R&D and production services throughout the whole industrial chain and the whole life cycle of chemical drugs, and has been committed to building a one-stop CRO/CDMO service platform integrating "chemistry + pharmacy + medicine". It has established a high-end drug R&D system and characteristic technology platforms that possess both innovation and competitiveness, such as the chiral drug synthesis and analysis technology platform, the crystal form and salt form screening technology platform, the complex preparation technology platform, the continuous flow engineering technology platform, the bio-enzyme engineering technology platform, and the preparative separation technology platform, etc. It can provide R&D and production services covering the whole industrial chain and the whole life cycle of drug R&D as well as its supporting active pharmaceutical ingredients and intermediates for clients.

Prev

Nanjing Vcare Won the 10th Place in the "Top 20 Chinese Pharmaceutical CRO Enterprises in 2023"

Next

Nanjing Vcare Helps Nanjing Chiatai Tianqing's Anti-tumor New Drug CXA03 to Obtain the Clinical Approval